Thus, we wonder whether PTP1B inhibitor has a synergistic effect with current immune checkpoint inhibitors such as PD1 or PDL1, TIM3, etc. We isolated mononuclear cancer cells from the bone marrow of AML patients to validate the effects of MSI-1436 in vitro. Here, HAVCR2 is linked to cancer.